相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Levoketoconazole, the 2S,4R Enantiomer of Ketoconazole, a New Steroidogenesis Inhibitor for Cushing's Syndrome Treatment
Sara G. Creemers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing's syndrome
Eliza B. Geer et al.
PITUITARY (2021)
Updates in the outcomes of radiation therapy for Cushing's disease
Monica Livia Gheorghiu
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
The treatment with pasireotide in Cushing's disease: effect of long-term treatment on clinical picture and metabolic profile and management of adverse events in the experience of a single center
C. Simeoli et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2020)
Efficacy of Temozolomide Therapy in Patients With Aggressive Pituitary Adenomas and Carcinomas-A German Survey
Ulf Elbelt et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Pasireotide treatment significantly reduces tumor volume in patients with Cushing's disease: results from a Phase 3 study
Andre Lacroix et al.
PITUITARY (2020)
Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase
Rosario Pivonello et al.
LANCET DIABETES & ENDOCRINOLOGY (2020)
Medical Treatment of Cushing's Disease: An Overview of the Current and Recent Clinical Trials
Rosario Pivonello et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Management of patients with persistent or recurrent Cushing's disease after initial pituitary surgery
Cristina Capatina et al.
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM (2020)
Methodological quality of case series studies: an introduction to the JBI critical appraisal tool
Zachary Munn et al.
JBI EVIDENCE SYNTHESIS (2020)
The incidence of endogenous Cushing's syndrome in the modern era
Sofie Wengander et al.
CLINICAL ENDOCRINOLOGY (2019)
Safety and Efficacy of Subcutaneous Pasireotide in Patients With Cushing's Disease: Results From an Open-Label, Multicenter, Single-Arm, Multinational, Expanded-Access Study
Maria Fleseriu et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Efficacy and safety of levoketoconazole in the treatment of endogenous Cushing's syndrome (SONICS): a phase 3, multicentre, open-label, single-arm trial
Maria Fleseriu et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
The medical treatment with pasireotide in Cushing's disease: an Italian multicentre experience based on real-world evidence
Rosario Pivonello et al.
ENDOCRINE (2019)
THE MULTIFARIOUS CUSHING'S LESSONS FROM A CASE SERIES
I. Ilie et al.
ACTA ENDOCRINOLOGICA-BUCHAREST (2019)
Preoperative medical treatment in Cushing's syndrome: frequency of use and its impact on postoperative assessment: data from ERCUSYN
Elena Valassi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Hepatic safety of ketoconazole in Cushing's syndrome: results of a Compassionate Use Programme in France
Jacques Young et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Effectiveness of medical treatment for Cushing's syndrome: a systematic review and meta-analysis
Leonie H. A. Broersen et al.
PITUITARY (2018)
Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial
Andre Lacroix et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Pasireotide treatment reduces cardiometabolic risk in Cushing's disease patients: an Italian, multicenter study
A. Albani et al.
ENDOCRINE (2018)
Effects of pasireotide treatment on coagulative profile: a prospective study in patients with Cushing's disease
Mattia Barbot et al.
ENDOCRINE (2018)
Metyrapone treatment in Cushing's syndrome: a real-life study
Filippo Ceccato et al.
ENDOCRINE (2018)
Cabergoline for Cushing's disease: a large retrospective multicenter study
A. Ferriere et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)
Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas
Helene Lasolle et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)
BIOCHEMICAL CONTROL DURING LONG-TERM FOLLOW-UP OF 230 ADULT PATIENTS WITH CUSHING DISEASE: A MULTICENTER RETROSPECTIVE STUDY
Eliza B. Geer et al.
ENDOCRINE PRACTICE (2017)
Limited value of cabergoline in Cushing's disease: a prospective study of a 6-week treatment in 20 patients
Pia Burman et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Osilodrostat, a potent oral 11β-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing's disease
Maria Fleseriu et al.
PITUITARY (2016)
A Single-Center 10-Year Experience with Pasireotide in Cushing's Disease: Patients' Characteristics and Outcome
L. Trementino et al.
HORMONE AND METABOLIC RESEARCH (2016)
PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement
Jessie McGowan et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2016)
The Role of Isotretinoin Therapy for Cushing's Disease: Results of a Prospective Study
Lucio Vilar et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2016)
KETOCONAZOLE TREATMENT IN CUSHING'S SYNDROME - RESULTS OF A TERTIARY REFERRAL CENTER IN ROMANIA
C. M. V. Ghervan et al.
ACTA ENDOCRINOLOGICA-BUCHAREST (2015)
Outcomes in patients with Cushing's disease undergoing transsphenoidal surgery: systematic review assessing criteria used to define remission and recurrence
Stephan Petersenn et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline
Lynnette K. Nieman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Effectiveness of Metyrapone in Treating Cushing's Syndrome: A Retrospective Multicenter Study in 195 Patients
Eleni Daniel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Assessment of the outcomes of the treatment of Cushing's disease in the hospitals of Castilla-La Mancha
Isabel Huguet et al.
ENDOCRINOLOGIA Y NUTRICION (2015)
Pasireotide can induce sustained decreases in urinary cortisol and provide clinical benefit in patients with Cushing's disease: results from an open-ended, open-label extension trial
Jochen Schopohl et al.
PITUITARY (2015)
The treatment with pasireotide in Cushing's disease: effects of long-term treatment on tumor mass in the experience of a single center
Chiara Simeoli et al.
ENDOCRINE (2015)
Increased long-term remission after adequate medical cortisol suppression therapy as presurgical treatment in Cushing's disease
O. F. C. van den Bosch et al.
CLINICAL ENDOCRINOLOGY (2014)
Efficacy of medical treatment in Cushing's disease: a systematic review
Monica R. Gadelha et al.
CLINICAL ENDOCRINOLOGY (2014)
Treatment effectiveness of pasireotide on health-related quality of life in patients with Cushing's disease
Susan M. Webb et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
Ketoconazole in Cushing's Disease: Is It Worth a Try?
Frederic Castinetti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Pasireotide monotherapy in Cushing's disease: a single-centre experience with 5-year extension of phase III Trial
Jessica MacKenzie Feder et al.
PITUITARY (2014)
Combination therapy for Cushing's disease: effectiveness of two schedules of treatment. Should we start with cabergoline or ketoconazole?
M. Barbot et al.
PITUITARY (2014)
Extended treatment of Cushing's disease with pasireotide: results from a 2-year, Phase II study
M. Boscaro et al.
PITUITARY (2014)
Metaprop: a Stata command to perform meta-analysis of binomial data
Victoria N. Nyaga et al.
ARCHIVES OF PUBLIC HEALTH (2014)
Long-term remission and recurrence rates in Cushing's disease: predictive factors in a single-centre study
Krystallenia I. Alexandraki et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
Cortisol diurnal rhythm and quality of life after successful medical treatment of Cushing's disease
R. van der Pas et al.
PITUITARY (2013)
A reappraisal of the medical therapy with steroidogenesis inhibitors in Cushing's syndrome
Elena Valassi et al.
CLINICAL ENDOCRINOLOGY (2012)
A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease
Annamaria Colao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
GRADE guidelines: 3. Rating the quality of evidence
Howard Balshem et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Management of Cushing disease
Nicholas A. Tritos et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
Cabergoline versus bromocriptine in the treatment of hyperprolactinemia: a systematic review of randomized controlled trials and meta-analysis
Vania dos Santos Nunes et al.
PITUITARY (2011)
Interpretation of random effects meta-analyses
Richard D. Riley et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
EFFICACY OF CABERGOLINE IN UNCURED (PERSISTENT OR RECURRENT) CUSHING DISEASE AFTER PITUITARY SURGICAL TREATMENT WITH OR WITHOUT RADIOTHERAPY
Anurag R. Lila et al.
ENDOCRINE PRACTICE (2010)
Cabergoline monotherapy in the long-term treatment of Cushing's disease
Ariane Godbout et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Pasireotide Alone or with Cabergoline and Ketoconazole in Cushing's Disease
Richard A. Feelders et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effectiveness of cabergoline in monotherapy and combined with ketoconazole in the management of Cushing's disease
Lucio Vilar et al.
PITUITARY (2010)
Treatment of Pituitary-Dependent Cushing's Disease with the Multireceptor Ligand Somatostatin Analog Pasireotide (SOM230): A Multicenter, Phase II Trial
M. Boscaro et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Approach to the Patient with Possible Cushing's Syndrome
Marco Boscaro et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
The Medical Treatment of Cushing's Disease: Effectiveness of Chronic Treatment with the Dopamine Agonist Cabergoline in Patients Unsuccessfully Treated by Surgery
Rosario Pivonello et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Ketoconazole revisited: a preoperative or postoperative treatment in Cushing's disease
F. Castinetti et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Use of cabergoline in persisting Cushing's disease
F. Illouz et al.
ANNALES D ENDOCRINOLOGIE (2006)
Recovery of bone mineral density after surgical cure, but not by ketoconazole treatment, in Cushing's syndrome
G Luisetto et al.
OSTEOPOROSIS INTERNATIONAL (2001)
分享论文
